Tag: 2bPrecise

Health IT Trends for 2019

Healthcare technology continues to proliferate the sector, the developments almost too many to track. The sector abounds with innovation and push forward in the name of better – even the minutest – advancements of care and better care outcomes. The coming year will be no different. As we enter the final year of the 21st century’s second decade, we’ve witnessed a tremendous amount of evolution in just 19 years. What role will our healthcare technology play in the healthcare industry in the next year?

A lot. And not just for a few, but members of many, many areas, even those peripherally involved with the boundaries of care. We must understand where current innovation is, but also the challenges these migrations attempt to solve. Being aware of the trends ahead can give us all a better grasp of how care delivery is changing and we can better understand how new areas can resolve real industry problems.

To help us navigate the year ahead for healthcare and its technology, the following are some of the trends that it leaders, observers, insiders, consultants and investors think are important or need to be taken notice of in 2019.

Continue Reading

Are Physicians Ready To Meet Consumer Demand For Genomics?

By Joel Diamond, MD, FAAFP, chief medical officer, 2bPrecise.

Joel Diamond, MD
Joel Diamond, MD

Patients are becoming more engaged in (and financially responsible for) their own care. As such, they are increasingly interested in information about their health risks and which courses of treatment have the best potential for success. In my practice, I have seen a sharp rise in the number of patients asking about genetic and genomic tests.

Healthcare consumers are drawn to the idea that this information can unlock answers to persistent health problems, or reveal risk for future issues. They want genetic information to lay out a clear path forward for prevention and treatment, perhaps indicating which medications will be most effective for their profile. It’s one of the reasons why direct-to-consumer genetic testing, such as 23andMe, has become so popular.

The precision medicine learning curve

Soon we will move from individual gene tests and panels to exome and full genome testing, some of which is happening today. As the concept of applying genomics and precision medicine gains momentum, physicians are enthusiastic about the potential of personalized care plans to improve patient outcomes.

But are physicians equipped with the right tools to put precision medicine into practice? For example, can we identify which patients might benefit from genetic testing? Do we know what test to order? How do we interpret results? How do we incorporate this information into the patient record? And of course, cost is always an issue: Who pays for these tests?

These are some of the many questions physicians are wrestling with today. If they have a clinical-genomic solution within the electronic health record (EHR) workflow, they can get some of the support they need to meet rising demand for personalized medicine and care plans.

3 trends to watch as consumers drive precision medicine into the mainstream

Consumer interest shows no signs of slowing, which will continue to bring new challenges and opportunities into the physician’s office. Trends include:

Continue Reading